Elevated total serum IgM predicts the presence of antiphospholipid antibodies in dysautonomia patients
What you need to know about migraine in Hughes syndrome patients
Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS)
Postural Tachycardia Syndrome (POTS) and other Autonomic Disorders in Antiphospholipid (Hughes) Syndrome
A Trial of Antithrombotic Therapy in Patients with Refractory Migraine and Antiphospholipid Antibodies: A retrospective study of 75 patients
Diagnosis of Mast Cell Activation Syndrome: A global “consensus-2”
Autoimmunity, Autonomic Neuropathy, and the HPV Vaccination: A Vulnerable Subpopulation
Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On
Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 patients
How we treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin Therapy
Excipient Reactivity in Patients with Mast Cell Activation Syndrome - In Press
Deep Capillary Retinal Ischemia and High-Titer Prothrombin-Associated Antiphospholipid Antibodies: A case series of three patients
Autonomic Neuropathy—in its many guises—as the Initial Manifestation of the Antiphospholipid Syndrome
Dosing considerations in the use of the Direct Oral Anticoagulants in the Antiphospholipid Syndrome
Case 9-2014: A woman with increasing dyspnea